HOME >> BIOLOGY >> NEWS
ACS News Service Weekly PressPac -- Nov. 15, 2006

alive and capable of growth afterward, they say.

"This has far-reaching implications and will enable significant advances to be made in technologies ranging from tissue engineering to regenerative medicine," Suwan N. Jayasinghe and Andrea Townsend-Nicholson state in their report. It appeared Nov. 13 in ACS' Biomacromolecules, a bimonthly journal. "The ability to electrospin biologically active threads and scaffolds of living organisms will be tremendously useful for the development of a whole host of novel bioengineering and medical applications."

Electrospinning is a well-established process for drawing fibers out of a thick polymer by use of an electric field. The scientists used an electrospinning approach in which a concentrated suspension of living cells flowed through a tiny inner needle while thick poly(dimethylsiloxane) flowed from an outer needle. The silicone material formed a fiber around the cells. One of the many topics awaiting study, the researchers said, is how the process affects the biological properties of the cells in the long term.

ARTICLE #1 FOR IMMEDIATE RELEASE
"Cell Electrospinning: A Unique Biotechnique for Encapsulating Living Organisms for Generating Active Biological Microthreads/Scaffolds"

DOWNLOAD PDF
http://pubs.acs.org/cgi-bin/sample.cgi/bomaf6/asap/pdf/bm060649h.pdf

DOWNLOAD HTML
http://pubs.acs.org/cgi-bin/sample.cgi/bomaf6/asap/html/bm060649h.html

CONTACT:

Suwan N. Jayasinghe, Ph.D.
University College London
London, United Kingdom
Phone: +44 (0) 207-679-2960
Fax: +44 (0) 207-388-0180
Email: s.iavasinghe@uc1.ac.uk


ARTICLE #2 FOR IMMEDIATE RELEASE

A simp
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
20-Nov-2006


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. ACS News Service Weekly PressPac -- May 23, 2007
2. ACS News Service Weekly PressPac -- May 16, 2007
3. ACS News Service Weekly PressPac -- May 9, 2007
4. ACS News Service Weekly PressPac -- May 2, 2007
5. ACS News Service Weekly PressPac -- April 25, 2007
6. ACS News Service Weekly PressPac -- April 18, 2007
7. ACS News Service Weekly PressPac -- April 11, 2007
8. ACS News Service Weekly PressPac -- March 28, 2007
9. ACS News Service Weekly PressPac -- March 21, 2007
10. ACS News Service Weekly PressPac -- March. 14, 2007
11. ACS News Service Weekly PressPac -- Feb. 21, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
Cached News: